연구성과로 돌아가기
2023 연구성과별 연구자 정보 (953 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Kweon, Young Oh | Kweon, YO | 9 | Kyungpook Natl Univ Hosp, Daegu, South Korea | robert.c.elston@gsk.com; | |||||
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Lim, Seng Gee | Lim, SG | 10 | Natl Univ Hlth Syst, Singapore, Singapore | AAD-9040-2020 | LIM, Seng | robert.c.elston@gsk.com; | |||
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Mngqibisa, Rosie | Mngqibisa, R | 11 | Enhancing Care Fdn, Durban, South Africa | JXM-3390-2024 | Mngqibisa, Rosie | robert.c.elston@gsk.com; | |||
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Piratvisuth, Teerha | Piratvisuth, T | 12 | NKC Inst Gastroenterol & Hepatol, Songkhla, Thailand | robert.c.elston@gsk.com; | |||||
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Sagalova, Olga | Sagalova, O | 13 | South Ural State Med Univ, Chelyabinsk, Russia | HJI-1475-2023 | Sagalova, Olga | 0000-0003-3814-7342 | Sagalova, Olga | robert.c.elston@gsk.com; | |
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Serfaty, Lawrence | Serfaty, L | 14 | HUS Hop Hautepierre, Strasbourg, France | GQP-1022-2022 | DEBACK, Claire | robert.c.elston@gsk.com; | |||
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Stepanova, Tatyana | Stepanova, T | 15 | Modern Med Clin, Moscow, Russia | robert.c.elston@gsk.com; | |||||
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Tsrancheva, Radoslava | Tsrancheva, R | 16 | Alexandrovska Univ Hosp, Sofia, Bulgaria | HNC-5384-2023 | Tsrancheva, Radoslava | robert.c.elston@gsk.com; | |||
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Xie, Qing | Xie, Q | 17 | Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai, Peoples R China | robert.c.elston@gsk.com; | |||||
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Yuen, Man-Fung | Yuen, MF | 18 | Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China | C-4466-2009 | Yuen, Richard Man Fung | robert.c.elston@gsk.com; | |||
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Macfarlane, Chelsea | Macfarlane, C | 19 | GSK, Waltham, MA USA | robert.c.elston@gsk.com; | |||||
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Corson, Stephen | Corson, S | 20 | PHASTAR, Glasgow, Lanark, Scotland | robert.c.elston@gsk.com; | |||||
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Dong, Jie | Dong, J | 21 | GSK, Shanghai, Peoples R China | robert.c.elston@gsk.com; | |||||
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Plein, Helene | Plein, H | 22 | GSK, Brentford, England | robert.c.elston@gsk.com; | |||||
| Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | Quinn, Geoff | Quinn, G | 23 | GSK, Stevenage, Herts, England | robert.c.elston@gsk.com; |
페이지 이동: